Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
about
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment ResponseAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaApplication of Different Imaging Methods in the Early Diagnosis of Primary Hepatic CarcinomaJSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of JapanGadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysisRadiological diagnosis of hepatocellular carcinomaRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIModel-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineConsensus report from the 7th International Forum for Liver Magnetic Resonance ImagingRecent advances in the imaging of hepatocellular carcinomaComparison of the Accuracy of DWI and Ultrasonography in Screening Hepatocellular Carcinoma in Patients With Chronic Liver Disease.Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.[Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria].CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver.Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.Gadoxetic acid-enhanced MRI outperformed MDCT in diagnosing small hepatocellular carcinoma: A meta-analysis.LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies.Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.Diffusion-weighted MRI and optimal b-value for characterization of liver lesions.Pretransplant diagnosis of hepatocellular carcinoma by gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging.
P2860
Q26740616-4AE56B1C-0D59-48D2-804F-63757E41E36DQ26772334-7985EF77-D571-4B39-B25E-4A2D6D7D4B29Q26773119-A14FCADA-E3EB-41C7-9403-D7FAF1C8488AQ26797521-F8E74FAE-EBF4-4ABF-9799-AC1015512018Q26798636-15C73C08-C7FB-4546-AE12-67AE6E2F50EBQ27027683-185BD5B1-07C2-4531-B8E8-5D9D0F58735BQ28075361-6D0B8673-A1BB-4D09-B3A2-BD48A6367079Q28087569-9437AC16-E232-42D0-A389-CA0D35D1B22AQ28088807-9C865AF1-A1A9-4C47-A243-D9AE609D2D92Q30415186-B3364454-D306-4877-8D92-AA0E6B3BB078Q30416604-36FACC65-9BAE-4549-BAC6-7C724A50A46AQ33561375-F891E958-10AF-4E43-BAD3-12880330EC21Q34663392-8ED9F8BD-E8F3-4DA1-A739-180E722DF6C5Q34681076-3072DA44-02AA-4C73-ABFB-C0D54A27BBD9Q37608667-762B318C-74D1-4CA6-AF45-57B442F443E0Q38869595-C7D3F873-6865-4140-86B9-3E59422C97FDQ40060177-4D9F6CC5-D652-4024-8907-8BCD311B28ABQ43906532-F893D813-B1A4-495E-9EEF-7B42589CBE49Q47821895-DE480692-D836-4CAA-BDE7-DA4465BD8413Q48792736-DCB79963-E475-4E4B-BC2E-9A322B9EA383Q53060683-5A76F28E-78A4-4A0B-AEBB-3A13FBE90343Q53097292-EF88D28F-CEBD-4AA4-B213-72A5A2A8CEDCQ53151193-D86EC77D-D50B-466B-8DBE-539C024194AD
P2860
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Validation of diagnostic crite ...... titis-induced liver cirrhosis.
@en
Validation of diagnostic crite ...... small hepatocellular carcinoma
@nl
type
label
Validation of diagnostic crite ...... titis-induced liver cirrhosis.
@en
Validation of diagnostic crite ...... small hepatocellular carcinoma
@nl
prefLabel
Validation of diagnostic crite ...... titis-induced liver cirrhosis.
@en
Validation of diagnostic crite ...... small hepatocellular carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Validation of diagnostic crite ...... titis-induced liver cirrhosis.
@en
P2093
Jiyoung Hwang Won Jae Lee
Mi Hee Lee
Min Jung Park
Young Kon Kim
P2860
P304
P356
10.1258/AR.2012.120262
P407
P577
2012-11-12T00:00:00Z